ir. Dennis Grimon
- ORCID iD
-
0000-0001-7298-6831
Show
Sort by
-
Understanding and engineering phage lysin specificity to treat polymicrobial Gram-negative infections
-
Exploiting the natural power of phage lysins as novel enzyme-based antibiotics to treat polymicrobial Gram-negative infections
-
Systematic engineering of lysins yields serum resistant and in vivo active compounds towards drug-resistant Acinetobacter baumannii
-
From design to function : an automation-enabled pipeline for the development of precision lysin therapeutics
-
‘Exquisite specificity’, if the context allows : endolysin evolution is a contingent outcome of phage-host molecular landscapes
-
- Journal Article
- A1
- open access
Single-cell analysis of yeast surface display for designer cellulosome applications using a fluorescent protein complex
-
- Journal Article
- A1
- open access
Engineering an antimicrobial chimeric endolysin that targets the phytopathogen Pseudomonas syringae pv. actinidiae
-
- Journal Article
- A1
- open access
Deep eutectic solvent enhances antibacterial activity of a modular lytic enzyme against Acinetobacter baumannii
-
- Journal Article
- A1
- open access
The new SH3b_T domain increases the structural and functional variability among SH3b-like CBDs from staphylococcal phage endolysins
-
- Conference Paper
- C3
- open access
Rapid and high-throughput evaluation of diverse configura-tions of engineered lysins using the VersaTile technique